DGKA and acute myeloid leukemia: The expression data were then correlated with the IC50 values of inhibitors targeting either DGKA (ritanserin) or DGKZ (DGKZ-IN4 and BAY 2965501) across AML cell lines and PBLs (Supplementary Figure S6).